Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Liabilities and Shareholders Equity (2016 - 2025)

Chemours (CC) has 12 years of Liabilities and Shareholders Equity data on record, last reported at $7.4 billion in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 1.69% year-over-year to $7.4 billion; the TTM value through Dec 2025 reached $29.8 billion, down 1.42%, while the annual FY2025 figure was $7.4 billion, 1.69% down from the prior year.
  • Liabilities and Shareholders Equity reached $7.4 billion in Q4 2025 per CC's latest filing, down from $7.5 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $8.2 billion in Q4 2023 and bottomed at $7.2 billion in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $7.6 billion, with a median of $7.5 billion recorded in 2021.
  • Peak YoY movement for Liabilities and Shareholders Equity: rose 8.38% in 2021, then dropped 8.88% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $7.6 billion in 2021, then grew by 1.19% to $7.6 billion in 2022, then grew by 7.87% to $8.2 billion in 2023, then fell by 8.88% to $7.5 billion in 2024, then decreased by 1.69% to $7.4 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $7.4 billion in Q4 2025, $7.5 billion in Q3 2025, and $7.5 billion in Q2 2025.